Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Clinical trial NCT06441331 · RECRUITING

Trial details

NCT number: NCT06441331
Sponsor: ITM Solucin GmbH
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Somatostatin Receptor Positive NETs Lymphoma Solid Tumor CNS Tumors Rhabdomyosarcoma Peripheral Primitive Neuroectodermal Tumor GIST

Start date: 2025-09-26
Primary completion: 2028-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.